PT-141 (Bremelanotide)
Category: Melanocortin Agonist
A melanocortin receptor agonist for sexual dysfunction in men and women.
Half-Life: 2.5 hours
Common Dosage: 1-2mg
Benefits
- Improves libido in both sexes
- Works independent of nitric oxide pathways
- Rapid onset (within 30-60 minutes)
- FDA-approved nasal form for female HSDD
Side Effects
- Nausea
- Flushing
- Headache
- Transient blood pressure changes
- Injection site irritation